연구정보
[경제] Financing research and development for new vaccines in Asia-Pacific developing countries
동남아시아 일반 국외연구자료 연구보고서 UNESCAP 발간일 : 2022-11-23 등록일 : 2022-12-04 원문링크
자료이용안내
국내외 주요 기관에서 발표하는 자료들을 수집하여 제공하고 있습니다. 수록 자료의 자세한 내용은 해당 기관으로 문의하시기 바랍니다.
There have been many important innovations in the landscape of vaccine development for neglected and emerging infectious diseases, such as the launch of public-private product development partnerships (PDPs). However, there is still a gap in funding the development of such vaccines, especially when it comes to financing late-stage trials. There is a financial risk in investing in late-stage trials, and there is no guarantee of a commercial market, particularly for the most neglected diseases of poverty. One result of the funding gap is that there are many infectious diseases with a high burden in the Asia-Pacific region for which there are no licensed, highly effective vaccines, including HIV/AIDS, tuberculosis, soil-transmitted helminths and schistosomiasis. There are also neglected infectious diseases that affect populations in the region where the existing vaccines have limitations, such as malaria, dengue, and Japanese encephalitis.
본 페이지에 등재된 자료는 운영기관(KIEP) 및 EMERiCs의 공식적인 입장을 대변하고 있지 않습니다.
